Amiodarone reduces plasma warfarin clearance in man
- PMID: 4092002
- PMCID: PMC1400826
- DOI: 10.1111/j.1365-2125.1985.tb05135.x
Amiodarone reduces plasma warfarin clearance in man
Abstract
Amiodarone is an effective antiarrhythmic agent whose use is associated with several drug interactions one of which is potentiation of the action of warfarin. The mechanism of this interaction has hitherto been unclear. We examined possible mechanisms in eight patients. Total plasma warfarin clearance was found to be reduced by amiodarone. No change was detected in the binding of warfarin to plasma proteins. No relationship was found between plasma amiodarone concentrations and the change in warfarin clearance.
Similar articles
-
In vitro amiodarone protein binding and its interaction with warfarin.Experientia. 1985 Mar 15;41(3):361-3. doi: 10.1007/BF02004505. Experientia. 1985. PMID: 3972082
-
Mechanism of warfarin potentiation by amiodarone: dose--and concentration--dependent inhibition of warfarin elimination.Eur J Clin Pharmacol. 1985;28(3):257-61. doi: 10.1007/BF00543320. Eur J Clin Pharmacol. 1985. PMID: 4007030
-
The potentiation of warfarin anticoagulation by amiodarone.Circulation. 1982 May;65(5):1025-9. doi: 10.1161/01.cir.65.5.1025. Circulation. 1982. PMID: 7074739
-
Clinical pharmacokinetics of amiodarone.Clin Pharmacokinet. 1984 Mar-Apr;9(2):136-56. doi: 10.2165/00003088-198409020-00002. Clin Pharmacokinet. 1984. PMID: 6370540 Review.
-
Clinical pharmacokinetics of the newer antiarrhythmic agents.Clin Pharmacokinet. 1984 Sep-Oct;9(5):375-403. doi: 10.2165/00003088-198409050-00001. Clin Pharmacokinet. 1984. PMID: 6437721 Review.
Cited by
-
Amiodarone pharmacokinetics. I. Acute dose-dependent disposition studies in rats.J Pharmacokinet Biopharm. 1986 Dec;14(6):601-13. doi: 10.1007/BF01067966. J Pharmacokinet Biopharm. 1986. PMID: 3820092
-
Pharmacokinetic drug interactions with amiodarone.Clin Pharmacokinet. 1989 Aug;17(2):130-40. doi: 10.2165/00003088-198917020-00005. Clin Pharmacokinet. 1989. PMID: 2673606 Review.
-
Investigation of patients with abnormal response to warfarin.Br J Clin Pharmacol. 1986 Jul;22(1):37-41. doi: 10.1111/j.1365-2125.1986.tb02877.x. Br J Clin Pharmacol. 1986. PMID: 3741725 Free PMC article.
-
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose.Eur J Clin Pharmacol. 2006 Apr;62(4):291-6. doi: 10.1007/s00228-006-0104-4. Epub 2006 Mar 22. Eur J Clin Pharmacol. 2006. PMID: 16552506 Clinical Trial.
-
Clinically significant drug interactions with the oral anticoagulants.Drug Saf. 1994 May;10(5):381-94. doi: 10.2165/00002018-199410050-00003. Drug Saf. 1994. PMID: 8037888 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical